Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
10 резултати
Method for maintaining or improving the synthesis of mucins
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION
This invention generally relates to methods for maintaining, improving or increasing the synthesis of mucins, especially in the gastrointestinal tract and lungs. The invention further relates to maintaining, improving or increasing the synthesis of mucins in a patient by
Mucin synthesis inhibitors
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
FIELD OF THE INVENTION
This invention relates to methods of modulating mucin synthesis and the therapeutic application of compounds in controlling mucin over-production associated with diseases such as asthma, chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic
Mucin synthesis inhibitors
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
FIELD OF THE INVENTION
This invention relates to methods of modulating mucin synthesis and the therapeutic application of compounds in controlling mucin over-production associated with diseases such as asthma, chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic
Mucin synthesis inhibitors
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
FIELD OF THE INVENTION
This invention relates to methods of modulating mucin synthesis and the therapeutic application of compounds in controlling mucin over-production associated with diseases such as asthma, chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic
Use of Akkermansia muciniphila for treating inflammatory conditions
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted electronically in ASCII format and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Apr. 5, 2018, is named P224214US_WO_ST25_3429641.txt and is 858 bytes in size.
FIELD OF
Compositions and methods for treating inflammatory bowel disease and airway inflammation
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
TECHNICAL FIELD
The present invention relates to compositions and methods of treating inflammatory diseases, including inflammatory bowel disease, airway inflammation, cancer, and other inflammatory disorders, and methods for carrying out the methods.
BACKGROUND OF INVENTION
Inflammatory Bowel
Mucin derived polypeptides
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
SEQUENCE LISTING
This application incorporates by reference in its entirety the Sequence Listing entitled "Mucin_ST25.txt" (28.0 KB), which was created on Apr. 27, 2011 and filed electronically herewith.
FIELD
The present disclosure relates to therapeutic mucin proteins. In particular, the present
Modulation of TIM receptor activity in combination with cytoreductive therapy
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION
The T cell/transmembrane, immunoglobulin, and mucin (TIM) gene family was positionally cloned in 2001 using a congenic mouse model of asthma. Since that time, a great deal of evidence has accumulated indicating that this gene family plays a critical role in regulating
T cell regulatory genes and methods of use thereof
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION
The astonishing complexity of the immune system is its greatest strength. The 10.sup.12-10.sup.14 possible antibody specificities, the delicate interplay between the various regulatory and effector cells, the restriction of T cell responses according to MHC antigens; all
Modulation of TIM receptor activity in combination with cytoreductive therapy
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION
The T cell/transmembrane, immunoglobulin, and mucin (TIM) gene family was positionally cloned in 2001 using a congenic mouse model of asthma. Since that time, a great deal of evidence has accumulated indicating that this gene family plays a critical role in regulating
Најкомплетнија база лековитог биља подржана науком
- Ради на 55 језика
- Биљни лекови потпомогнути науком
- Препознавање биљака по слици
- Интерактивна ГПС мапа - означите биље на локацији (ускоро)
- Читајте научне публикације повезане са вашом претрагом
- Претражите лековито биље по њиховим ефектима
- Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима
Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима
